Eijkelkamp, W.B.A., et al. Albuminuria is a target for renoprotective therapy independentfrom blood pressure in patients with type 2 diabetic nephropathy: Post hoc analysis fromthe Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan(RENAAL) trial. Journal of the American Society of Nephrology 18, 1540-1546 (2007). The gene discussed is AGT; the disease is type 2 diabetes nephropathy.